ClinicalTrials.gov
ClinicalTrials.gov Menu

Augmentative and Alternative Communication (AAC) and Lexical Gain in Children With Down Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00689988
Recruitment Status : Completed
First Posted : June 4, 2008
Last Update Posted : June 4, 2008
Sponsor:
Information provided by:
University of Sao Paulo

June 2, 2008
June 4, 2008
June 4, 2008
July 2005
October 2007   (Final data collection date for primary outcome measure)
Performance on a initial and final lexical assessments, after 12 months of speech-language therapy [ Time Frame: 12 months ]
Same as current
No Changes Posted
Performance on longitudinal follow-up of twelve months of speech-language therapy with AAC use [ Time Frame: 12 months ]
Same as current
Not Provided
Not Provided
 
Augmentative and Alternative Communication (AAC) and Lexical Gain in Children With Down Syndrome
Augmentative and Alternative Communication and Lexical Gain in Children With Down Syndrome: Pilot Study
Children with Down syndrome (DS) have language development particularities that have negative effects in the communication capacity. By this way, Augmentative and Alternative Communication (AAC) is indicated to this population. The aim of this study was to verify the AAC impact in the lexical gain of children with DS.
Five children with DS, with the same cognitive level, participated in this study. Longitudinal follow-up of twelve months of speech-language therapy with AAC use was undertaken. A lexical evaluation was done at the beginning and the end of this follow-up. Correct responses in the lexical evaluation were increased, but not necessarily in the spoken modality. The comparisons showed significant results in use of substitutions processes, and to no-answers.
Interventional
Not Applicable
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Down Syndrome
Behavioral: speech-language therapy with AAC intervention
speech-language intervention in weekly 40-minutes sessions, without the presence of parents or caregivers, and 5 to 10-minutes to parents training and orientation
Experimental: SG
Study Group: five children with Down syndrome submitted to speech-language intervention with AAC intervention
Intervention: Behavioral: speech-language therapy with AAC intervention
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
5
Same as current
June 2008
October 2007   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • genetic diagnosis of Down syndrome
  • be at the preoperational period
  • good health conditions
  • expressive language impairment (communication by vocal and gestures, predominantly)

Exclusion Criteria:

  • presence of major malformations
  • presence of another genetic syndrome
  • severe neonatal asphyxia, hearing impairment or visual
Sexes Eligible for Study: All
5 Years to 11 Years   (Child)
Yes
Contact information is only displayed when the study is recruiting subjects
Brazil
 
 
NCT00689988
05/1149
Yes
Not Provided
Not Provided
Suelly Cecilia Olivan Limongi, University of Sao Paulo
University of Sao Paulo
Not Provided
Principal Investigator: Sandra CF Pires, PhD student University of São Paulo
Study Chair: Suelly CO Limongi, PhD University of São Paulo
University of Sao Paulo
June 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP